Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.
Clinical trial NCT04721821 · COMPLETED
Trial details
- NCT number
- NCT04721821
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-22
- Primary completion
- 2021-11-29
- Enrollment
- 7807
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.